Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study

  1. the DCCT/EDIC Research Group*
  1. 1Diabetes Unit and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
  2. 2The Biostatistics Center, The George Washington University, Rockville, MD
  3. 3Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, MN
  1. Corresponding author: Paula McGee, paulaf{at}bsc.gwu.edu.

Abstract

The association of chronic glycemia, measured by HbA1c, with long-term complications of type 1 diabetes has been well established in the Diabetes Control and Complications Trial (DCCT) and other studies. The role of intermediate-term and acute glycemia and of glucose variability on microvascular and cardiovascular disease (CVD) is less clear. In order to examine the interrelationships among long-term, intermediate-term, and acute measures of glucose and its daily variability, we compared HbA1c, glycated albumin (GA), and seven-point glucose profile concentrations measured longitudinally in a case-cohort subpopulation of the DCCT. HbA1c and GA were closely correlated with each other and with the mean blood glucose (MBG) calculated from the seven-point profile. The associations of glucose variability and postprandial concentrations with HbA1c and GA were relatively weak and were further attenuated when MBG was included in multivariate models. In the case-cohort analyses, HbA1c and GA had similar associations with retinopathy and nephropathy, which were strengthened when both measures were considered together. Only HbA1c was significantly associated with CVD. The demonstrated interrelationships among different measures of glycemia will need to be considered in future analyses of their roles in the development of long-term complications of type 1 diabetes.

Footnotes

  • This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db13-0782/-/DC1.

  • * A complete list of the members of the DCCT/EDIC Research Group is provided in the supplementary appendix published in the article by the DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365:2366–2376.

  • See accompanying commentary, p. 45.

  • Received May 16, 2013.
  • Accepted August 23, 2013.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

| Table of Contents

This Article

  1. Diabetes vol. 63 no. 1 282-290
  1. Supplementary Data
  2. All Versions of this Article:
    1. db13-0782v1
    2. 63/1/282 most recent